Jacksonville: 904-281-5757 | Memphis: 901-843-1045
Downtown Orlando: 407-425-5100 | Orlando SODO: 407-425-5100
RSV is the most common cause of bronchiolitis and pneumonia in children younger than 1 year of age in the United States and easily spreads from person to person. You can get it from direct contact with someone who has it or by touching infected objects, such as toys or surfaces, such as countertops. People infected with RSV are usually contagious for 3 to 8 days. However, some infants, and people with weakened immune systems, can continue to spread the virus even after they stop showing symptoms for as long as 4 weeks. Washing your hands often and not sharing eating and drinking utensils are simple ways to help prevent the spread of RSV infection.
RSV vaccination clinical trials, like those at CNS Healthcare, can help you explore new options. Interested in a vaccination for RSV? Find out more about enrolling vaccination clinical trials available by selecting one of the below locations near you. Use the form on the page to schedule a free, in-office consultation to find out if a RSV vaccination trial is right for you.
RSV is caused by a virus and spread when an infected person coughs or sneezes. The virus enters the body through the nose or mouth or very often through the eyes (when people rub their eyes with a hand that has touched infected secretions.)
1. Abnormally fast breathing (tachypnea)
2. “Caving-in” of the chest in between the ribs and under the ribs (chest wall retractions)
3. “Spreading-out” of the nostrils with every breath (nasal flaring)
Since opening our doors in 1996, CNS Healthcare has had the privilege of assisting in the development of some of the most widely prescribed medicines in the world. We continue to lead the way in providing the clinical research necessary to identify medications for the FDA to review and, once approved, physicians to prescribe. CNS has conducted thousands of clinical trials, improved millions of lives, and is proud to have helped in the FDA approval of nearly 100 new treatments.